Logo image of NBA.LS

NOVABASE SGPS SA (NBA.LS) Stock Fundamental Analysis

Europe - ELI:NBA - PTNBA0AM0006 - Common Stock

8.85 EUR
0 (0%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

4

Overall NBA gets a fundamental rating of 4 out of 10. We evaluated NBA against 73 industry peers in the IT Services industry. NBA has an average financial health and profitability rating. NBA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year NBA was profitable.
In the past year NBA has reported a negative cash flow from operations.
Each year in the past 5 years NBA has been profitable.
NBA had a positive operating cash flow in 4 of the past 5 years.
NBA.LS Yearly Net Income VS EBIT VS OCF VS FCFNBA.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

NBA's Return On Assets of 6.62% is fine compared to the rest of the industry. NBA outperforms 71.23% of its industry peers.
Looking at the Return On Equity, with a value of 19.56%, NBA belongs to the top of the industry, outperforming 80.82% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.93%, NBA is in line with its industry, outperforming 57.53% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NBA is significantly below the industry average of 20.36%.
The last Return On Invested Capital (9.93%) for NBA is above the 3 year average (4.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.62%
ROE 19.56%
ROIC 9.93%
ROA(3y)12.18%
ROA(5y)9.24%
ROE(3y)28.94%
ROE(5y)22.64%
ROIC(3y)4.51%
ROIC(5y)4.85%
NBA.LS Yearly ROA, ROE, ROICNBA.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

The Profit Margin of NBA (6.58%) is better than 69.86% of its industry peers.
In the last couple of years the Profit Margin of NBA has declined.
Looking at the Operating Margin, with a value of 8.81%, NBA is in the better half of the industry, outperforming 64.38% of the companies in the same industry.
NBA's Operating Margin has improved in the last couple of years.
NBA has a Gross Margin (66.06%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NBA has declined.
Industry RankSector Rank
OM 8.81%
PM (TTM) 6.58%
GM 66.06%
OM growth 3Y-6%
OM growth 5Y4.53%
PM growth 3Y-8.63%
PM growth 5Y-23.21%
GM growth 3Y-3.03%
GM growth 5Y-2.81%
NBA.LS Yearly Profit, Operating, Gross MarginsNBA.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NBA is creating some value.
The number of shares outstanding for NBA has been increased compared to 1 year ago.
NBA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NBA has an improved debt to assets ratio.
NBA.LS Yearly Shares OutstandingNBA.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NBA.LS Yearly Total Debt VS Total AssetsNBA.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

NBA has an Altman-Z score of 3.90. This indicates that NBA is financially healthy and has little risk of bankruptcy at the moment.
NBA's Altman-Z score of 3.90 is amongst the best of the industry. NBA outperforms 87.67% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that NBA is not too dependend on debt financing.
NBA's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. NBA outperforms 65.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 3.9
ROIC/WACC1.33
WACC7.47%
NBA.LS Yearly LT Debt VS Equity VS FCFNBA.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

NBA has a Current Ratio of 1.62. This is a normal value and indicates that NBA is financially healthy and should not expect problems in meeting its short term obligations.
NBA has a better Current ratio (1.62) than 79.45% of its industry peers.
NBA has a Quick Ratio of 1.62. This is a normal value and indicates that NBA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NBA (1.62) is better than 86.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
NBA.LS Yearly Current Assets VS Current LiabilitesNBA.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

NBA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.06%.
The earnings per share for NBA have been decreasing by -21.81% on average. This is quite bad
NBA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.99%.
Measured over the past years, NBA shows a small growth in Revenue. The Revenue has been growing by 3.35% on average per year.
EPS 1Y (TTM)-88.06%
EPS 3Y-11.05%
EPS 5Y-21.81%
EPS Q2Q%45.31%
Revenue 1Y (TTM)18.99%
Revenue growth 3Y-1.12%
Revenue growth 5Y3.35%
Sales Q2Q%-5.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.99%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBA.LS Yearly Revenue VS EstimatesNBA.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NBA.LS Yearly EPS VS EstimatesNBA.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

1

4. Valuation

4.1 Price/Earnings Ratio

NBA is valuated quite expensively with a Price/Earnings ratio of 44.25.
NBA's Price/Earnings ratio is a bit more expensive when compared to the industry. NBA is more expensive than 68.49% of the companies in the same industry.
When comparing the Price/Earnings ratio of NBA to the average of the S&P500 Index (27.67), we can say NBA is valued expensively.
The Price/Forward Earnings ratio is 31.29, which means the current valuation is very expensive for NBA.
Based on the Price/Forward Earnings ratio, NBA is valued a bit more expensive than 69.86% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.33, NBA is valued a bit more expensive.
Industry RankSector Rank
PE 44.25
Fwd PE 31.29
NBA.LS Price Earnings VS Forward Price EarningsNBA.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NBA.LS Per share dataNBA.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of NBA may justify a higher PE ratio.
PEG (NY)2.65
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 17.20%, NBA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.97, NBA pays a better dividend. On top of this NBA pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, NBA pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.2%

5.2 History

The dividend of NBA is nicely growing with an annual growth rate of 17.87%!
Dividend Growth(5Y)17.87%
Div Incr Years1
Div Non Decr Years1
NBA.LS Yearly Dividends per shareNBA.LS Yearly Dividends per shareYearly Dividends per share 2019 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

NBA pays out 551.68% of its income as dividend. This is not a sustainable payout ratio.
The dividend of NBA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP551.68%
EPS Next 2YN/A
EPS Next 3YN/A
NBA.LS Yearly Income VS Free CF VS DividendNBA.LS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
NBA.LS Dividend Payout.NBA.LS Dividend Payout, showing the Payout Ratio.NBA.LS Dividend Payout.PayoutRetained Earnings

NOVABASE SGPS SA

ELI:NBA (10/23/2025, 7:00:00 PM)

8.85

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-31 2025-07-31
Earnings (Next)02-18 2026-02-18/amc
Inst Owners3.92%
Inst Owner ChangeN/A
Ins Owners30.89%
Ins Owner ChangeN/A
Market Cap340.02M
Revenue(TTM)130.35M
Net Income(TTM)8.58M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 17.2%
Yearly Dividend1.52
Dividend Growth(5Y)17.87%
DP551.68%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.25
Fwd PE 31.29
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 7.75
P/tB 10.29
EV/EBITDA N/A
EPS(TTM)0.2
EY2.26%
EPS(NY)0.28
Fwd EY3.2%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS3.39
BVpS1.14
TBVpS0.86
PEG (NY)2.65
PEG (5Y)N/A
Graham Number2.27
Profitability
Industry RankSector Rank
ROA 6.62%
ROE 19.56%
ROCE 15.29%
ROIC 9.93%
ROICexc 15.65%
ROICexgc 20.25%
OM 8.81%
PM (TTM) 6.58%
GM 66.06%
FCFM N/A
ROA(3y)12.18%
ROA(5y)9.24%
ROE(3y)28.94%
ROE(5y)22.64%
ROIC(3y)4.51%
ROIC(5y)4.85%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.95%
ROCE(5y)7.47%
ROICexgc growth 3YN/A
ROICexgc growth 5Y20.37%
ROICexc growth 3YN/A
ROICexc growth 5Y18.77%
OM growth 3Y-6%
OM growth 5Y4.53%
PM growth 3Y-8.63%
PM growth 5Y-23.21%
GM growth 3Y-3.03%
GM growth 5Y-2.81%
F-Score4
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 3.9
F-Score4
WACC7.47%
ROIC/WACC1.33
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.25%
Cap/Sales(5y)1.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.06%
EPS 3Y-11.05%
EPS 5Y-21.81%
EPS Q2Q%45.31%
EPS Next Y16.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.99%
Revenue growth 3Y-1.12%
Revenue growth 5Y3.35%
Sales Q2Q%-5.83%
Revenue Next Year10.99%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y167.35%
EBIT growth 3Y-7.05%
EBIT growth 5Y8.03%
EBIT Next Year40%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-144.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.83%
OCF growth 3YN/A
OCF growth 5YN/A